Dr. Christopher Ryan Spock, MD

Dr. Spock practices at Gardens Plastic Surgery in Cape Coral, Florida.

Dr. Spock's NPI, 1679705677, was assigned on August 10, 2009. Dr. Spock graduated from Yale School of Medicine in 2009. Dr. Spock holds Florida license ME118605.

Dr. Spock's primary practice is Gardens Plastic Surgery, at 413 Del Prado S Blvd, Cape Coral, FL 33990 in Lee County. The practice phone is (239) 313-2515.

Dr. Spock's primary practice is Gardens Plastic Surgery in Cape Coral, Florida. The medical group on file is AQUA Dermatology. Dmand AI also links Dr. Spock to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spock practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Spock's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Spock is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Spock's licenses on file in 7 states: Florida, California, Ohio, New Jersey, New York, Pennsylvania and Virginia.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Spock treats.

CMS data shows 4,406 Medicare services from Dr. Spock across 27 procedure codes in 2024, for 1,005 Medicare patients. Medicare paid $736,381 for them. Every service was in an office.

CMS counts 1,005 Medicare patients who saw Dr. Spock in 2024. The largest group is 75 to 84, with 432 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Spock's median patient age at 76, with 45% women.

In 2024, Dr. Spock wrote 1,261 Medicare Part D claims for 670 patients. 98% of them were for generic drugs. CMS names the drug for 1,141 of them, across 17 drugs with 11 or more claims each, at $16,223 in total drug cost. In 2023, CMS named 1,173 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Spock for performance year 2024, reported as part of a group. Dr. Spock accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 499 procedures of skin biopsy by Dr. Spock, more than 95% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Spock, published from 2012 to 2019. 2012 was the busiest year, with 2. The most frequent topics are Magnetic Resonance Imaging, Activities of Daily Living and Arthroscopy. Dr. Spock has published most often in J Bone Joint Surg Am. Dr. Spock's most frequent co-authors are Robert S. Kirsner, MD, Robert G. Marx, MD and Brent Earl Schultz, MD.

CMS Open Payments shows 442 general payments to Dr. Spock from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $2,334.

Dr. Spock graduated from Yale School of Medicine in 2009.

Dr. Spock is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.